nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.226	0.297	CbGbCtD
Lovastatin—ABCC2—Spironolactone—dilated cardiomyopathy	0.187	0.246	CbGbCtD
Lovastatin—ABCC2—Furosemide—dilated cardiomyopathy	0.128	0.168	CbGbCtD
Lovastatin—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0901	0.118	CbGbCtD
Lovastatin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0693	0.091	CbGbCtD
Lovastatin—ABCB1—Spironolactone—dilated cardiomyopathy	0.061	0.0801	CbGbCtD
Lovastatin—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.0073	0.0441	CcSEcCtD
Lovastatin—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.00615	0.0372	CcSEcCtD
Lovastatin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00416	0.0251	CcSEcCtD
Lovastatin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00363	0.0219	CcSEcCtD
Lovastatin—Leg pain—Lisinopril—dilated cardiomyopathy	0.00359	0.0217	CcSEcCtD
Lovastatin—CYP2C9—cardial valve—dilated cardiomyopathy	0.00292	0.479	CbGeAlD
Lovastatin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00265	0.016	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00265	0.016	CcSEcCtD
Lovastatin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00252	0.0152	CcSEcCtD
Lovastatin—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00251	0.0152	CcSEcCtD
Lovastatin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00235	0.0142	CcSEcCtD
Lovastatin—Vasculitis—Furosemide—dilated cardiomyopathy	0.00226	0.0137	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00225	0.0136	CcSEcCtD
Lovastatin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00211	0.0128	CcSEcCtD
Lovastatin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00193	0.0116	CcSEcCtD
Lovastatin—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00189	0.0114	CcSEcCtD
Lovastatin—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00187	0.0113	CcSEcCtD
Lovastatin—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00183	0.011	CcSEcCtD
Lovastatin—Alopecia—Spironolactone—dilated cardiomyopathy	0.0018	0.0109	CcSEcCtD
Lovastatin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00179	0.0108	CcSEcCtD
Lovastatin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00178	0.0107	CcSEcCtD
Lovastatin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00171	0.0103	CcSEcCtD
Lovastatin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0017	0.0103	CcSEcCtD
Lovastatin—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00168	0.0101	CcSEcCtD
Lovastatin—Purpura—Furosemide—dilated cardiomyopathy	0.00166	0.01	CcSEcCtD
Lovastatin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00165	0.00994	CcSEcCtD
Lovastatin—Malaise—Spironolactone—dilated cardiomyopathy	0.0016	0.00966	CcSEcCtD
Lovastatin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00159	0.00959	CcSEcCtD
Lovastatin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00149	0.00901	CcSEcCtD
Lovastatin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00146	0.00882	CcSEcCtD
Lovastatin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00145	0.00875	CcSEcCtD
Lovastatin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00144	0.00872	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00144	0.00872	CcSEcCtD
Lovastatin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00142	0.00856	CcSEcCtD
Lovastatin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00138	0.00831	CcSEcCtD
Lovastatin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00137	0.00829	CcSEcCtD
Lovastatin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00137	0.00827	CcSEcCtD
Lovastatin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00136	0.0082	CcSEcCtD
Lovastatin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00134	0.00808	CcSEcCtD
Lovastatin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00133	0.00805	CcSEcCtD
Lovastatin—Injury—Lisinopril—dilated cardiomyopathy	0.00131	0.0079	CcSEcCtD
Lovastatin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00126	0.00764	CcSEcCtD
Lovastatin—HDAC2—Notch Signaling Pathway—PSEN1—dilated cardiomyopathy	0.00126	0.0186	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—VCL—dilated cardiomyopathy	0.00124	0.0184	CbGpPWpGaD
Lovastatin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00124	0.00747	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00122	0.0074	CcSEcCtD
Lovastatin—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00122	0.018	CbGpPWpGaD
Lovastatin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0012	0.00726	CcSEcCtD
Lovastatin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00119	0.00721	CcSEcCtD
Lovastatin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00115	0.00695	CcSEcCtD
Lovastatin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00114	0.00691	CcSEcCtD
Lovastatin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00108	0.00654	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00108	0.00654	CcSEcCtD
Lovastatin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00107	0.00644	CcSEcCtD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.00105	0.0155	CbGpPWpGaD
Lovastatin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00105	0.00633	CcSEcCtD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—ITGB1—dilated cardiomyopathy	0.00104	0.0154	CbGpPWpGaD
Lovastatin—Influenza—Lisinopril—dilated cardiomyopathy	0.00104	0.00628	CcSEcCtD
Lovastatin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00103	0.00622	CcSEcCtD
Lovastatin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00102	0.00619	CcSEcCtD
Lovastatin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00102	0.00616	CcSEcCtD
Lovastatin—ITGAL—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.000994	0.0147	CbGpPWpGaD
Lovastatin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000991	0.00598	CcSEcCtD
Lovastatin—HDAC2—Notch Signaling Pathway—PSEN1—dilated cardiomyopathy	0.000987	0.0146	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00098	0.0145	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—PSEN2—dilated cardiomyopathy	0.000968	0.0143	CbGpPWpGaD
Lovastatin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000958	0.00578	CcSEcCtD
Lovastatin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000957	0.00578	CcSEcCtD
Lovastatin—Flatulence—Furosemide—dilated cardiomyopathy	0.000951	0.00575	CcSEcCtD
Lovastatin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000949	0.00573	CcSEcCtD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000948	0.014	CbGpPWpGaD
Lovastatin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000945	0.00571	CcSEcCtD
Lovastatin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000928	0.00561	CcSEcCtD
Lovastatin—ITGAL—heart—dilated cardiomyopathy	0.000925	0.152	CbGeAlD
Lovastatin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000921	0.00556	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000919	0.00555	CcSEcCtD
Lovastatin—HDAC2—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.000915	0.0136	CbGpPWpGaD
Lovastatin—Rash—Spironolactone—dilated cardiomyopathy	0.000913	0.00551	CcSEcCtD
Lovastatin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000912	0.00551	CcSEcCtD
Lovastatin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00091	0.00549	CcSEcCtD
Lovastatin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000909	0.00549	CcSEcCtD
Lovastatin—Headache—Spironolactone—dilated cardiomyopathy	0.000907	0.00548	CcSEcCtD
Lovastatin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000901	0.00544	CcSEcCtD
Lovastatin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00087	0.00525	CcSEcCtD
Lovastatin—Vertigo—Furosemide—dilated cardiomyopathy	0.000867	0.00524	CcSEcCtD
Lovastatin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000864	0.00522	CcSEcCtD
Lovastatin—Nausea—Spironolactone—dilated cardiomyopathy	0.00086	0.0052	CcSEcCtD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—RAC1—dilated cardiomyopathy	0.000836	0.0124	CbGpPWpGaD
Lovastatin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000832	0.00503	CcSEcCtD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—PSEN2—dilated cardiomyopathy	0.000813	0.012	CbGpPWpGaD
Lovastatin—HMGCR—TOR Signaling—RPS6KB1—dilated cardiomyopathy	0.000806	0.0119	CbGpPWpGaD
Lovastatin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000804	0.00485	CcSEcCtD
Lovastatin—Confusional state—Furosemide—dilated cardiomyopathy	0.000794	0.0048	CcSEcCtD
Lovastatin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000788	0.00476	CcSEcCtD
Lovastatin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000787	0.00475	CcSEcCtD
Lovastatin—Flushing—Lisinopril—dilated cardiomyopathy	0.000772	0.00466	CcSEcCtD
Lovastatin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000771	0.00466	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—TTN—dilated cardiomyopathy	0.000768	0.0114	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—PSEN2—dilated cardiomyopathy	0.000759	0.0112	CbGpPWpGaD
Lovastatin—Anorexia—Furosemide—dilated cardiomyopathy	0.000751	0.00454	CcSEcCtD
Lovastatin—Chills—Lisinopril—dilated cardiomyopathy	0.000747	0.00451	CcSEcCtD
Lovastatin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000735	0.00444	CcSEcCtD
Lovastatin—HMGCR—TOR Signaling—RAC1—dilated cardiomyopathy	0.000728	0.0108	CbGpPWpGaD
Lovastatin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000714	0.00431	CcSEcCtD
Lovastatin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000709	0.00428	CcSEcCtD
Lovastatin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000707	0.00427	CcSEcCtD
Lovastatin—Back pain—Lisinopril—dilated cardiomyopathy	0.000701	0.00423	CcSEcCtD
Lovastatin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000696	0.00421	CcSEcCtD
Lovastatin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000685	0.00414	CcSEcCtD
Lovastatin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000683	0.00412	CcSEcCtD
Lovastatin—Fatigue—Furosemide—dilated cardiomyopathy	0.000679	0.0041	CcSEcCtD
Lovastatin—Tremor—Lisinopril—dilated cardiomyopathy	0.000679	0.0041	CcSEcCtD
Lovastatin—Pain—Furosemide—dilated cardiomyopathy	0.000674	0.00407	CcSEcCtD
Lovastatin—Constipation—Furosemide—dilated cardiomyopathy	0.000674	0.00407	CcSEcCtD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—PSEN2—dilated cardiomyopathy	0.000672	0.00996	CbGpPWpGaD
Lovastatin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000672	0.00406	CcSEcCtD
Lovastatin—ITGAL—Hemostasis—ACTN2—dilated cardiomyopathy	0.000666	0.00987	CbGpPWpGaD
Lovastatin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000662	0.004	CcSEcCtD
Lovastatin—Malaise—Lisinopril—dilated cardiomyopathy	0.000653	0.00395	CcSEcCtD
Lovastatin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000651	0.00393	CcSEcCtD
Lovastatin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000649	0.00392	CcSEcCtD
Lovastatin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000648	0.00392	CcSEcCtD
Lovastatin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000644	0.00389	CcSEcCtD
Lovastatin—Urticaria—Furosemide—dilated cardiomyopathy	0.000626	0.00378	CcSEcCtD
Lovastatin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000623	0.00376	CcSEcCtD
Lovastatin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000623	0.00376	CcSEcCtD
Lovastatin—ITGAL—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.000623	0.00923	CbGpPWpGaD
Lovastatin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000617	0.00372	CcSEcCtD
Lovastatin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000617	0.00372	CcSEcCtD
Lovastatin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000617	0.00372	CcSEcCtD
Lovastatin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000615	0.00371	CcSEcCtD
Lovastatin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000609	0.00368	CcSEcCtD
Lovastatin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000603	0.00364	CcSEcCtD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—PSEN2—dilated cardiomyopathy	0.000599	0.00888	CbGpPWpGaD
Lovastatin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000596	0.0036	CcSEcCtD
Lovastatin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000591	0.00357	CcSEcCtD
Lovastatin—Infection—Lisinopril—dilated cardiomyopathy	0.000587	0.00355	CcSEcCtD
Lovastatin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00058	0.00351	CcSEcCtD
Lovastatin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000579	0.0035	CcSEcCtD
Lovastatin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000572	0.00847	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—VCL—dilated cardiomyopathy	0.000566	0.00839	CbGpPWpGaD
Lovastatin—Asthenia—Furosemide—dilated cardiomyopathy	0.000565	0.00341	CcSEcCtD
Lovastatin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000563	0.0034	CcSEcCtD
Lovastatin—Pruritus—Furosemide—dilated cardiomyopathy	0.000557	0.00337	CcSEcCtD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—RAF1—dilated cardiomyopathy	0.000554	0.00822	CbGpPWpGaD
Lovastatin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000539	0.00326	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000539	0.00325	CcSEcCtD
Lovastatin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000535	0.00323	CcSEcCtD
Lovastatin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000531	0.00321	CcSEcCtD
Lovastatin—HDAC2—myocardium—dilated cardiomyopathy	0.00053	0.0869	CbGeAlD
Lovastatin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000527	0.00318	CcSEcCtD
Lovastatin—Dizziness—Furosemide—dilated cardiomyopathy	0.000521	0.00315	CcSEcCtD
Lovastatin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00052	0.00314	CcSEcCtD
Lovastatin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000514	0.0031	CcSEcCtD
Lovastatin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00051	0.00308	CcSEcCtD
Lovastatin—Pain—Lisinopril—dilated cardiomyopathy	0.000506	0.00305	CcSEcCtD
Lovastatin—Constipation—Lisinopril—dilated cardiomyopathy	0.000506	0.00305	CcSEcCtD
Lovastatin—Vomiting—Furosemide—dilated cardiomyopathy	0.000501	0.00303	CcSEcCtD
Lovastatin—ITGAL—Focal Adhesion—RAC1—dilated cardiomyopathy	0.0005	0.00742	CbGpPWpGaD
Lovastatin—Rash—Furosemide—dilated cardiomyopathy	0.000497	0.003	CcSEcCtD
Lovastatin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000496	0.003	CcSEcCtD
Lovastatin—Headache—Furosemide—dilated cardiomyopathy	0.000494	0.00298	CcSEcCtD
Lovastatin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000487	0.00294	CcSEcCtD
Lovastatin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000483	0.00292	CcSEcCtD
Lovastatin—HMGCR—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000479	0.0071	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000478	0.00709	CbGpPWpGaD
Lovastatin—HMGCR—myocardium—dilated cardiomyopathy	0.000478	0.0785	CbGeAlD
Lovastatin—HDAC2—Signaling by NOTCH—PSEN2—dilated cardiomyopathy	0.000477	0.00707	CbGpPWpGaD
Lovastatin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00047	0.00284	CcSEcCtD
Lovastatin—Nausea—Furosemide—dilated cardiomyopathy	0.000468	0.00283	CcSEcCtD
Lovastatin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000467	0.00282	CcSEcCtD
Lovastatin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000467	0.00282	CcSEcCtD
Lovastatin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000436	0.00263	CcSEcCtD
Lovastatin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000424	0.00256	CcSEcCtD
Lovastatin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000418	0.00253	CcSEcCtD
Lovastatin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000404	0.00244	CcSEcCtD
Lovastatin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000391	0.00236	CcSEcCtD
Lovastatin—HDAC2—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	0.000387	0.00574	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000377	0.00559	CbGpPWpGaD
Lovastatin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000376	0.00227	CcSEcCtD
Lovastatin—Rash—Lisinopril—dilated cardiomyopathy	0.000373	0.00225	CcSEcCtD
Lovastatin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000372	0.00225	CcSEcCtD
Lovastatin—Headache—Lisinopril—dilated cardiomyopathy	0.00037	0.00224	CcSEcCtD
Lovastatin—HDAC2—heart—dilated cardiomyopathy	0.00037	0.0607	CbGeAlD
Lovastatin—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000364	0.0054	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000355	0.00526	CbGpPWpGaD
Lovastatin—Nausea—Lisinopril—dilated cardiomyopathy	0.000351	0.00212	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000346	0.00513	CbGpPWpGaD
Lovastatin—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000335	0.00497	CbGpPWpGaD
Lovastatin—HMGCR—heart—dilated cardiomyopathy	0.000334	0.0548	CbGeAlD
Lovastatin—ITGAL—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000332	0.00492	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—ITGB1—dilated cardiomyopathy	0.000317	0.0047	CbGpPWpGaD
Lovastatin—HMGCR—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000316	0.00469	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000309	0.00459	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—RAC1—dilated cardiomyopathy	0.000301	0.00446	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000295	0.00438	CbGpPWpGaD
Lovastatin—HMGCR—cardiac atrium—dilated cardiomyopathy	0.000285	0.0468	CbGeAlD
Lovastatin—HMGCR—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000285	0.00422	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—ITGB1—dilated cardiomyopathy	0.000284	0.00421	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000279	0.00413	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000253	0.00374	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000246	0.00364	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—CD36—dilated cardiomyopathy	0.000243	0.00359	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TTN—dilated cardiomyopathy	0.000236	0.0035	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000231	0.00343	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—RAC1—dilated cardiomyopathy	0.000229	0.00339	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000228	0.00338	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000228	0.00337	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000222	0.00329	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.000221	0.00327	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000214	0.00317	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—GPX1—dilated cardiomyopathy	0.000214	0.00317	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000213	0.00316	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000211	0.00313	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD36—dilated cardiomyopathy	0.00021	0.00311	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ACTN2—dilated cardiomyopathy	0.000205	0.00303	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—RAC1—dilated cardiomyopathy	0.000201	0.00298	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—FAS—dilated cardiomyopathy	0.0002	0.00297	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000198	0.00293	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000195	0.00289	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000192	0.00284	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000183	0.00271	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000181	0.00268	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VCL—dilated cardiomyopathy	0.000174	0.00258	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ANKRD1—dilated cardiomyopathy	0.000168	0.00249	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000162	0.0024	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000161	0.00239	CbGpPWpGaD
Lovastatin—CYP2C9—heart—dilated cardiomyopathy	0.000161	0.0265	CbGeAlD
Lovastatin—HDAC2—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.000159	0.00236	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TAZ—dilated cardiomyopathy	0.000158	0.00234	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000154	0.00229	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000153	0.00227	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—RAF1—dilated cardiomyopathy	0.000152	0.00225	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00015	0.00222	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00015	0.00222	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00015	0.00222	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ITGB1—dilated cardiomyopathy	0.000149	0.00221	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.000148	0.00219	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000147	0.00218	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000146	0.00216	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SDHA—dilated cardiomyopathy	0.000143	0.00212	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000141	0.00208	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00014	0.00207	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000137	0.00203	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000137	0.00203	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000137	0.00203	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000136	0.00202	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000132	0.00196	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000131	0.00194	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	0.000129	0.00191	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000128	0.0019	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000128	0.0019	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD36—dilated cardiomyopathy	0.000127	0.00188	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000127	0.00188	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—RAC1—dilated cardiomyopathy	0.00012	0.00178	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NR3C2—dilated cardiomyopathy	0.00012	0.00178	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000119	0.00177	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.00173	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000117	0.00173	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000114	0.00169	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000112	0.00166	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000111	0.00164	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	0.00011	0.00162	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000106	0.00157	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000105	0.00156	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000105	0.00156	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000102	0.00152	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000101	0.0015	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.99e-05	0.00148	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	9.91e-05	0.00147	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	9.54e-05	0.00141	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	9.47e-05	0.0014	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.39e-05	0.00139	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.11e-05	0.00135	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—EGFR—dilated cardiomyopathy	8.98e-05	0.00133	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—EGFR—dilated cardiomyopathy	8.93e-05	0.00132	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	8.9e-05	0.00132	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ITGB1—dilated cardiomyopathy	8.74e-05	0.0013	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.72e-05	0.00129	CbGpPWpGaD
Lovastatin—ABCB1—heart—dilated cardiomyopathy	8.71e-05	0.0143	CbGeAlD
Lovastatin—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	8.68e-05	0.00129	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	8.63e-05	0.00128	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.57e-05	0.00127	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.49e-05	0.00126	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	8.16e-05	0.00121	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	8.05e-05	0.00119	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	7.96e-05	0.00118	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—RAF1—dilated cardiomyopathy	7.95e-05	0.00118	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.64e-05	0.00113	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NPPA—dilated cardiomyopathy	7.52e-05	0.00111	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	7.49e-05	0.00111	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CD36—dilated cardiomyopathy	7.46e-05	0.0011	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	7.38e-05	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—RAF1—dilated cardiomyopathy	7.35e-05	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—RAC1—dilated cardiomyopathy	7.03e-05	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NPPA—dilated cardiomyopathy	6.98e-05	0.00103	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	6.77e-05	0.001	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PSEN2—dilated cardiomyopathy	6.76e-05	0.001	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.61e-05	0.000979	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.43e-05	0.000952	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.43e-05	0.000952	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.98e-05	0.000885	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	5.76e-05	0.000853	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—dilated cardiomyopathy	5.45e-05	0.000808	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	5.41e-05	0.000802	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.26e-05	0.00078	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.24e-05	0.000776	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.12e-05	0.000759	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.05e-05	0.000748	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—dilated cardiomyopathy	5.04e-05	0.000747	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.99e-05	0.000739	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.95e-05	0.000734	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	4.89e-05	0.000725	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.74e-05	0.000702	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	4.69e-05	0.000695	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—RAF1—dilated cardiomyopathy	4.66e-05	0.00069	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.61e-05	0.000684	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.5e-05	0.000667	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.45e-05	0.000659	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.38e-05	0.000649	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.34e-05	0.000644	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.34e-05	0.000644	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	4.24e-05	0.000628	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.21e-05	0.000623	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.21e-05	0.000623	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	4.18e-05	0.00062	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	4.09e-05	0.000606	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	4.08e-05	0.000605	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	4.06e-05	0.000601	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.95e-05	0.000585	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.91e-05	0.000579	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GPX1—dilated cardiomyopathy	3.88e-05	0.000575	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.85e-05	0.00057	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.81e-05	0.000565	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.79e-05	0.000561	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.78e-05	0.000561	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CD36—dilated cardiomyopathy	3.78e-05	0.00056	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.69e-05	0.000547	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.48e-05	0.000516	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.45e-05	0.000511	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AGT—dilated cardiomyopathy	3.4e-05	0.000504	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RAC1—dilated cardiomyopathy	3.4e-05	0.000504	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.28e-05	0.000486	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.23e-05	0.000479	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	3.16e-05	0.000469	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	3.08e-05	0.000457	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.07e-05	0.000455	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.04e-05	0.000451	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	2.78e-05	0.000411	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.77e-05	0.000411	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	2.69e-05	0.000399	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.68e-05	0.000397	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.64e-05	0.000391	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	2.62e-05	0.000388	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.6e-05	0.000386	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.59e-05	0.000383	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.52e-05	0.000373	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.52e-05	0.000373	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.38e-05	0.000353	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	2.36e-05	0.00035	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	2.34e-05	0.000347	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.31e-05	0.000342	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	2.28e-05	0.000338	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGT—dilated cardiomyopathy	2.28e-05	0.000337	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.28e-05	0.000337	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.27e-05	0.000336	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RAF1—dilated cardiomyopathy	2.26e-05	0.000334	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.25e-05	0.000334	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.25e-05	0.000333	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	2.19e-05	0.000324	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.14e-05	0.000318	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	2.13e-05	0.000316	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.1e-05	0.000312	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	2.05e-05	0.000304	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.05e-05	0.000304	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.02e-05	0.0003	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	2e-05	0.000297	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.95e-05	0.000289	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.92e-05	0.000284	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.85e-05	0.000273	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.84e-05	0.000273	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.79e-05	0.000265	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.76e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.61e-05	0.000239	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.58e-05	0.000234	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—dilated cardiomyopathy	1.55e-05	0.000229	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.000197	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.3e-05	0.000193	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.29e-05	0.000192	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000173	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.000171	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.000166	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.08e-05	0.00016	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.03e-05	0.000152	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	0.00015	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1e-05	0.000149	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1e-05	0.000148	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.77e-06	0.000145	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	9.45e-06	0.00014	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	9.37e-06	0.000139	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	9.21e-06	0.000136	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	9.13e-06	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	9.01e-06	0.000134	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.8e-06	0.00013	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	8.29e-06	0.000123	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	8.22e-06	0.000122	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.18e-06	9.16e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.02e-06	8.92e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.42e-06	8.03e-05	CbGpPWpGaD
